Ivascular S.l.u.
Clinical trials sponsored by Ivascular S.l.u., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New stent and shorter blood thinners could make heart treatment safer Results expected Jan 2027 (estimated)
- New catheter aims to suck out stroke clots fast Results expected Feb 2027 (estimated)
- New catheter aims to quickly clear Stroke-Causing clots Results expected Jul 2027 (estimated)
-
Can a new stent keep complex aortic aneurysms safely sealed?
Disease control By invitation onlyThis study looks at how well the iCover stent works when used as a bridging stent during a procedure called fenestrated endovascular aneurysm repair (fEVAR) for complex abdominal aortic aneurysms. The goal is to see if the stent stays open and keeps the aneurysm sealed without co…
Sponsor: iVascular S.L.U. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New stent and shorter blood thinners could make heart treatment safer
Disease control OngoingThis phase 3 trial tests two things at once in 2312 people with coronary artery disease: a new drug-coated stent (Angiolite) versus a standard stent, and a shorter course of blood thinners versus the usual longer course. The goal is to see if the new stent works as well and if sh…
Phase 3 • Sponsor: iVascular S.L.U. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC